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Since February 1, 1980, 515 morbidly obese patients have un-
dergone the Greenville gastric bypass (GGB) operation. Of these,
212 (41.2%) were euglycemic, 288 (55.9%) were either diabetic
or had glucose intolerance, and 15 (2.9%) were unable to complete
the evaluation. After the operation, only 30 (5.8%) patients re-
mained diabetic (and 20 of these improved), 457 (88.7%) became
and have remained euglycemic, and inadequate data prevented
classification of the other 28 (5.4%). The patients who failed to
return to normal glucose values were older and their diabetes
was of longer duration than those who did. The effect of the
GGB was not only limited to the correction of abnormal glucose
levels. The GGB also corrected the abnormal levels of fasting
insulin and glycosylated hemoglobin in a cohort of 52 consecutive
severely obese patients with non-insulin-dependent diabetes. The
GGB effectively controls weight. If morbid obesity is defined as
100 pounds over ideal body weight, 89% of the patients are no
longer "morbidly" obese within 2 years. In most patients, the
control of the weight has been well maintained during the 11
years of follow-up; most of the upward creep in weight of 20.8%
between 24 and 132 months was from the 49 (9.5%) patients
who had staple line breakdowns between the large and small
gastric pouches. Non-insulin-dependent diabetes, previously
considered a chronic unrelenting disease, can be controlled in
the severely obese by the gastric bypass. Whether the correction
of glucose metabolism affects the complications of diabetes is
unknown. Whether the gastric bypass should be considered for
patients with advanced non-insulin-dependent diabetes but who
are not severely obese deserves consideration. The GGB has an
unacceptably high rate of staple line failure. Accordingly, the
authors have recently changed their procedure to one that divides
the stomach rather than partitions it with staples.
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DA IABETES MELLITUS IS one of our most serious
diseases. It accelerates the development of ath-
erosclerosis, doubles the risk for stroke, and in-
creases the risk of heart attacks twofold to threefold.
Through its damage to the microvasculature, diabetes
produces retinopathies, blindness, nephropathy, and
neuropathy. In addition, there are broader systemic effects,
such as the lessening of resistance to infection. The eco-
nomic impact of the disease is enormous; in 1985 it was
estimated to be $4 billion and may well be twice that high
given the inflation in health care costs. Although the exact
prevalence is unknown, the usual estimate is that 10 mil-
lion Americans have the disease and, ofthese, 1.25 million
take insulin, 1 to 1.5 million are on oral antidiabetic
agents, and another two to three million are being man-
aged by diet alone. Many remain undiagnosed. The dis-
ease is generally classified into two groups: type I diabetes
or insulin-dependent diabetes, which afflicts about
200,000 to 300,000, and the far more common type II
diabetes or non-insulin-dependent diabetes mellitus
(NIDDM), which accounts for more than 95% of the
cases. '
The basis for the current treatment of NIDDM is the
maintenance of euglycemia and normal insulin levels.
This "control of the diabetes" is considered the best ap-
proach to prevent the acute and chronic complications
of diabetes and to ameliorate those changes that are al-
ready present.2 Unfortunately, euglycemia cannot be
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achieved in most patients with NIDDM because they are
usually overweight and resistant to dietary controls. In
fact, their excess weight is a major factor in precipitating
the overt diabetes, especially in those predisposed by
heredity.3 In Rochester, Minnesota,4 59% of cases of di-
abetes were diagnosed among men and women with a
body mass index (BMI) greater than 28.3 kg/M2, and in
the Nurses' Health Study,5 61% of the diabetic women
aged 30 to 64 had BMIs of 29 kg/M2 or more. Among
these obese women, 94% of NIDDM prevalence was at-
tributed to obesity.
Over the last 11 years, we have treated 515 severely
obese patients, most ofwhom demonstrated abnormalities
ofglucose and insulin metabolism, with surgery to control
their weight. The operation, the Greenville gastric bypass
(GGB), limits intake by the fashioning of a small gastric
pouch, delays gastric emptying with a small outlet, and
bypasses the foregut with a Roux-en-Y anastomosis. The
procedure is effective: in addition to inducing long-term
weight loss, it helps in the control of hypertension and
returns many of those handicapped by severe obesity to
functional effectiveness.
Four years ago, we6 reported that the GGB operation
restored some ofthe severely obese patients with NIDDM
to euglycemia. This article is a report of our continued
studies of the effect of the procedure on the glucose and
insulin metabolism of these patients.
Materials and Methods: Clinical Studies
From February 1, 1980 to August 1, 1991, 515 con-
secutive morbidly obese patients (each exceeding their
ideal body weight by 100 pounds or more) underwent the
standardized GGB.
Demographic Data
The 515 patients included 359 white and 79 black
women as well as 64 white and 13 black men. Of the
group, 360 were married, 44 were divorced, 83 were single,
18 were separated, and 10 were widows. The job status
survey showed that 324 were employed and 191 were not.
Diabetic Status
The state of the diabetes was defined in accordance
with the standards of the National Diabetes Data Group
(Table 1).7 Ofthe 515 patients, 500 completed oral glucose
tolerance tests; in 15 (2.9%), a lack of full data (because
ofa missing or suspicious sample in the glucose tolerance
test curve) prevented accurate assessment. Of the 500
evaluable patients, 212 (41.2%) were classified as normal,
and 288 (55.9%) demonstrated abnormal glucose metab-
olism. Of the 288 patients with abnormal glucose metab-
olism, 137 (26.6%) were classified as NIDDM, 63 (12.2%)
as glucose impaired, and 88 (17.1%) as undefined.
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TABLE 1. Diagnostic Criteria for Diabetes Mellitus and Impaired
Glucose Tolerance as Defined by the National Diabetes Data Group*
Non-Insulin-dependent Diabetes Mellitus
Criteria for diabetes mellitus: Diagnosis of diabetes mellitus in
nonpregnant adults should be restricted to those who have one of
the following:
1. A random plasma glucose level of 200 mg/dL or greater plus classic
signs and symptoms of diabetes mellitus, including polydipsia,
polyuria, polyphagia, and weight loss.
2. A fasting plasma glucose level of 140 mg/dL or greater on at least
two occasions.
3. A fasting plasma glucose level of less than 140 mg/dL plus
sustained elevated plasma glucose levels during at least two oral
glucose tolerance tests. The 2-hr sample and at least one other
between 0 and 2 hr after the 75-g glucose dose should be 200
mg/dL or greater. Oral glucose tolerance testing is not necessary if
the patient has a fasting plasma glucose level of 140 mg/dL or
greater.
Impaired Glucose Tolerance
Criteria for impaired glucose tolerance: Diagnosis of impaired glucose
tolerance in nonpregnant adults should be restricted to those who
have all of the following:
1. A fasting plasma glucose level of less than 140 mg/dL.
2. A 2-hr oral glucose tolerance test plasma glucose level between 140
and 200 mg/dL.
3. An intervening oral glucose tolerance test plasma glucose value of
20 mg/dL or greater.
* We have added another category, "undefined": Those patients with
abnormal plasma glucose values but who do not fit into either of the
above two groups.
Patient Selection and Eligibility
Patients of either sex were considered eligible for in-
clusion ifthey met the following criteria: (1) ages between
18 and 65 years (although an exception was made for a
girl of 16); (2) severely obese, in other words, they exceeded
their ideal body weight as given in the midpoint of the
1983 Metropolitan Life Insurance Tables by 100 pounds
or more; (3) suitable operative risks after evaluation of
their physical and emotional status; (4) capable of un-
derstanding the operation and the postoperative conse-
quences and instructions; (5) agreement to long-term fol-
low-up; (6) informed consent; and (7) funding for the sur-
gery and the various required tests. Patients were excluded
during the course of the evaluation if they (1) were not
sufficiently obese; (2) had a history ofalcohol or substance
abuse within the last 5 years; (3) had a history of severe
psychiatric dysfunction, especially evidence of suicidal
attempts, serious depression, or paranoia; and (4) had in-
appropriate expectations of the surgery in spite of coun-
seling, and met strong continued opposition by other
family members.
Preoperative Evaluation
We have continued to decrease the intensity ofour pre-
operative evaluation over the 11 years of the study with
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the elimination of those tests, such as levels of trace ele-
ments, that have produced too few significant abnormal
levels to warrant the effort and the expense. Our current
approach includes the following examinations:
1. complete history and physical examination with mea-
surement of waist-to-hip ratios, body mass index (kg/
mi2), and vital signs
2. routine admission studies, including complete blood
count, SMA-12, electrolytes, vitamin B12 level, thyroid-
stimulating hormone, prothrombin time, partial
thromboplastin time, urinalysis, posteroanterior and
lateral chest roentgenograms, electrocardiogram
3. glucose tolerance test
4. specialized tests for the evaluation of surgical risk, in-
cluding pulmonary function testing and determination
of anergy with skin tests (PPD, mumps, and fungus)
5. immersion hydrostatic weighing to determine body
composition
6. the evaluation of mental health, physical function, and
role function with a standardized interview with the
project psychologist or psychiatrist
This description ofour method is not intended to serve
as a prescription for others treating severe obesity. We
recognize that our evaluation, carried out to support our
various studies, is more detailed and rigorous than would
be needed in daily bariatric surgical practice. Even so, our
patients have only rarely complained about the extent of
the workup. It is our impression that most patients find
the attention comforting rather than an annoyance.
The Surgical Intervention: The Greenville Gastric Bypass
We have carried out the identical operation, shown in
Figure 1, as described by Pories,8 a variation of the pro-
cedure originally described by Mason and Ito,9 since Feb-
ruary 1, 1980. Details in bariatric surgery often mean the
difference between success and failure. The operation is
technically demanding and the administration ofthe gen-
eral anesthesia in these often huge individuals is a chal-
lenge. In those patients with marginal cardiopulmonary
function, the insertion of a Swan-Ganz catheter and pre-
operative stabilization in an intensive care unit can reduce
operative risk. A Gomez self-retaining retractor or one of
the other retracting mechanisms that is clamped to the
operating table is essential to achieve adequate exposure.
The abdomen is entered through a high midline incision
that extends around the umbilicus in most cases. If the
exploration does not demonstrate contraindications to the
procedure, the dissection around the upper portion ofthe
stomach is begun by inserting the index finger gently into
the angle at the cardia to the left of the esophagus. At this
point there is a weak, thin area ofthe posterior peritoneum
that is easily entered by the dissecting finger. The dissec-
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FIG. 1. The Greenville gastric bypass. The operation creates a proximal
gastric pouch of 20-30 mL by the placement of a transverse double row
of staples that empties into a 40-cm jejunal limb through an 8-mm gas-
troenterostomy. The high rate of staple line failure (9.5%) has led us
recently to divide the stomach between the two staple lines.
tion is gently continued behind the esophagus and cardia.
The channel is complete when the finger is brought out,
not at the right side of the esophagus, but just below the
first arcade of branches from the left gastric artery about
2.3 to 3.0 cm below the cardia. A large Malecot catheter,
from which the bulbous end has been cut, is used to pull
one limb of the TA-90 four-staple-line device through
the passage. A proximal pouch measuring 4 cm in width
and 1.5 cm in height is then separated from the stomach
by firing the staples. A figure-of-eight 3-0 polypropylene
suture is placed at the end of the staple line to close the
ends securely and to serve as guy sutures during the anas-
tomosis. The stomach is then divided by cutting between
the two paired lines of staples, and both staple lines are
then oversewn with 3-0 absorbable suture. (The division
of the stomach is new: the partitioning of the stomachs
of the 515 patients reported in this report was accom-
plished with the stapler alone. The high incidence of staple
line failure and the success ofgastric division for revisions
of failed gastric bypasses has convinced us that division
is the better approach and, accordingly, on October 25,
1991, we changed our protocol, altering our procedure
for the first time in over 11 years.) The jejunum is divided
at the apex of the first or second arcade (depending on
which provides a longer Roux-en-Y limb), about 40 cm
from the ligament of Treitz, with a cutting stapling device,
and the distal end is then sutured to the gastric pouch.
The anastomosis is sewn to fit snugly around a 0.8-cm
Salem sump tube in two layers with continuous 3-0 poly-
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propylene suture. The entero-enterostomy is then com-
pleted by joining the proximal jejunum end-to-side to the
distal jejunum with the cutting and the TA 55 staplers. It
is important to fasten the Roux loop to the mesocolon
with several sutures to prevent an internal hernia and to
oversew the bleeders inside the entero-enterostomy before
closing the intestine. The abdomen is closed with a run-
ning, double-stranded, 1-absorbable monofilament suture.
The skin is closed with skin staples without a subcutaneous
suture line. The operation usually can be performed in 1
to 2 hours; blood loss rarely exceeds 300 mL.
Postoperative Care
In general, the postoperative care of bariatric patients
resembles that after standard abdominal surgery in high-
risk patients and therefore will not be described in detail
except to emphasize the need for prophylactic antibiotics,
careful monitoring ofvital signs, fluid balance, and glucose
metabolism, and the requirement for appropriate furni-
ture and equipment to manage these massive patients.
The first 24 hours are particularly critical because of the
serious consequences of a leak or intra-abdominal infec-
tion in the morbidly obese. If the pulse remains over 120
for more than 4 hours without an evident reason, if there
is a rise in body temperature to over 39 C (102 F), or if
the patient looks ill in spite of normal signs, prompt
emergency exploration and the addition of other anti-
biotics may be needed. Examinations with the swallow of
radiopaque materials to demonstrate leaks are not reliable
and should not be used as a reason for failure to re-explore.
Neglect of a perforation or intra-abdominal infection is
associated with a high mortality rate. Patients generally
spend the first night in the critical care unit or a monitored
ward bed for close observation and then spend the rest of
their hospital stay (usually a total of 5 to 6 days) on surgical
wards. Nasogastric tubes are usually removed on the third
day. When the patients pass flatus, they are begun on
water at 1 oz/hour, followed by the addition of a high-
protein fluid preparation, half-strength on the next day,
and full-strength on the day of discharge. Patients are
maintained on the full-strength preparation for 2 weeks
and then advanced slowly to a regular diet.
Follow-up
Follow-up has been rigorous. Return visits are timed
weekly for the first month, then every third month for a
year, and for every 6 months for continuing follow-up.
Over the 11 years we have maintained follow-up with all
but 17 of the 515 patients (96.7%).
Biopsies for Studies ofInsulin Action
A 10-mL sample of venous blood and biopsies of fat,
liver, muscle, and pancreas were obtained in several co-
horts of patients in accordance with protocols approved
by the institutional review boards of the East Carolina
University School of Medicine and the Pitt County Me-
morial Hospital. The blood and cold steel biopsies were
obtained as soon as the abdomen was opened and after a
thorough exploration showed no contraindications to the
biopsies. The specimens of fat, measuring about 3 X 3
X 1 cm, were removed from (1) subcutaneous fat, (2) pro-
peritoneal fat, and (3) omental fat. The liver samples,
measuring 2 X 2 X 3 cm, were usually obtained from the
leading edge ofthe left lobe, but sometimes from the right,
depending on the exposure. Hemostasis and closure of
the defect were obtained with serosal running sutures of
3-0 absorbable braided suture. The strips ofrectus muscle,
measuring 1 X 0.5 X 3 cm were obtained by blunt ele-
vation of the fibers from the muscle bed, clamping these
into a specially designed clamp to maintain their stretch,
and transecting the fibers proximally and distally to the
clamp. Pancreatic biopsies have only been done recently.
These samples, measuring 0.3 X 0.3 X 0.3 cm, were re-
moved from the inferior side of the body of the pancreas
after incising the peritoneum at the junction of the me-
socolon and the posterior peritoneum. After the removal
of the specimen, the pancreatic capsule was closed with
one suture of 3-0 monofilament absorbable suture and
covered, with the peritoneum closed with the same ma-
terial. To our knowledge, and after continuing rigorous
review of our records, we know of no instance in which
any of the biopsies produced a complication.
Our methods for isolating insulin-responsive human
hepatocytes,'° human skeletal muscle," and human
adipocytes'2 have been previously described. Results from
these in vitro studies have been recently reviewed by Caro
and his associates. 13
Results
Control of Weight
Weight reduction in these patients has been dramatic
and well maintained over the 132 months of follow-up.
Table 2 presents the weight loss of all 515 patients who
have undergone the GGB in time intervals after surgery,
in mean weight in pounds, in mean percentage of excess
weight loss, and in mean percentage of ideal body weight
as indicated by the 1983 Metropolitan Life Insurance Ta-
bles. If severe obesity is defined as 100 pounds over ideal
weight, 89% ofthe patients are no longer "morbidly" obese
within 2 years. Figure 2 demonstrates that there is some
weight gain between 24 and 132 months (from a mean
of 183 to 221 pounds or 20.8%), reflecting those 49 (9.5%)
patients who had staple line breakdowns and others who
learned to "outeat" their pouches with high-calorie liquids
or continued snacking.
"Reversal" ofDiabetes
Table 3 shows that of the 500 severely obese patients
who completed the oral glucose tolerance test and un-
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TABLE 2. Weight Loss History With Greenville Gastric Bypass After 11 Years' Follow-up
% Excess % of Ideal
Weight (lb) Weight Lost Body Weight
Time N* Mean (Range) Mean (Range) Mean (Range)
Before operation 515 296 (196-565) 0 216(140-327)
3 mo 474 239 (124-490) 37 (6-103) 174 (97-307)
6 mo 470 211(100-441) 55(0-137) 154 (73-282)
12 mo 439 187(104-466) 71(13-124) 136(85-268)
24 mo 348 183 (105-367) 72 (9-116) 134 (88-248)
36 mo 274 197 (112-411) 65 (-10-114) 142 (88-256)
48 mo 248 199 (114-413) 61 (-22-112) 145(87-253)
60 mo 236 201(107-428) 60 (-15-118) 147 (86-263)
72 mo 201 203 (121-399) 58 (8-133) 148 (79-270)
84 mo 172 203 (113-378) 59 (-10-109) 150(94-273)
96 mo 132 204(130-357) 56 (8-97) 153 (103-259)
108 mo 97 205 (125-392) 55 (6-95) 151 (104-276)
120 mo 44 198 (130-350) 56 (9-106) 149 (97-226)
132 mo 11 221 (174-346) 42(29-58) 162 (139-212)
* No. of patients with recorded weight within each time interval ranging from ±15 days at 3 mo after operation to ±5 mo at 11 yr after operation.
derwent the GGB, 288 (57.6%) were either diabetic (137)
or had glucose intolerance (151). Ofthe 137 patients with
NIDDM, 107 (78.1%) went into clinical remission, 20
(14.6%) improved, and eight (5.8%) demonstrated no
change. Two patients (1.5%) died in the perioperative pe-
riod and could not be evaluated. Ofthe 151 patients who
were not classified as NIDDM but who had abnormal
preoperative glucose values, 13 had no follow-up glucose
data. Of the 138 who did, all but two (98.6%) maintained
normal fasting blood glucose levels. The two (1.2%) who
did not return to euglycemia progressed to NIDDM.
Before surgery, 24 received insulin and another 25 were
under treatment with oral antidiabetic agents. After sur-
gery, three were subsequently placed on insulin and 11
on the oral medications.
The effect of the GGB is not limited to glucose levels
alone. Table 4 demonstrates that the GGB corrected the
abnormal levels of fasting blood glucose, fasting insulin,
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FlG. 2. Weight loss induced by the gastric bypass is well maintained over
the 132 months of observation. The modest upward creep by the 11th
year is primarily caused by the failure of the gastric staple lines.
and glycosylated hemoglobin in a cohort of 52 consecutive
severely obese patients with NIDDM.
The 28 NIDDM patients who did not go into complete
remission and the two glucose-impaired patients who
progressed to NIDDM were examined in detail. Factors
that may be associated with these failures include four
patients with staple line breakdowns, two patients with
gastric outlet dilatation, eight patients with rising weight
that may be indicative of dietary indiscretion or undi-
agnosed staple breakdown, one patient with Hodgkin's
disease, and one patient with severe arthritis and steroid-
associated weight gain, leaving 15 patients without dis-
cernible risk factors.
Patients with good glucose control were about 8 years
younger (41.9 ± 1.9 versus 49.6 ± 2.8 years), and their
diabetes was of far shorter duration (1.75 ± 0.69 versus
8.79 ± 2.8 years) than those patients who had poor glucose
control.
The level ofpreoperative fasting glucose also determines
the degree of postoperative control, as shown in Figure 3.
The patients with the higher postoperative glucose values
experienced greater drops in fasting blood sugar than their
TABLE 3. The Control ofNIDDM With theGastricBypass (n = 515)
Before After
Operation Operation
Euglycemic 212 (41.2%) 457 (88.7%)
Hyperglycemic 288 (55.9%) 30 (5.8%)
Non-insulin-dependent
diabetes mellitus 137 (26.6%)
Impaired glucose tolerance 63 (12.2%)
Undefined, but abnormal 88 (17.1%)
Inadequate data 15 (2.9%) 28 (5.4%)
NIDDM, non-insulin-dependent diabetes mellitus.
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TABLE 4. The Correction ofAbnormal Glucose Metabolism
After the Gastric Bypass (n = 52)
Before 1 Yr After
Operation Operation
Average weight (kg) 120.1 ± 4.4 83.0 ± 3.3
Fasting blood glucose (mg/dL) 212.3 ± 20.8 117.3 ± 11.5
Fasting insulin (,uM/mL) 44.8 ± 4.1 13.4 ± 2.0
HbAlc 10.8 ± 0.6 6.4 ± 0.2
more normal counterparts, but leveled out at levels that
were still abnormal.
The improvements in insulin levels, glycosylated he-
moglobin (HbA lc), and glucose levels do not parallel each
other consistently. In contrast to the insulin levels that
fall predictably after gastric bypass (Fig. 4), the levels of
HbA c (Fig. 5) and fasting blood sugar (Fig. 6) on the
same group of patients show a much wider scatter. The
reasons for this unexpected difference in the behavior of
these diabetic indices is not clear.
The glucose tolerance curves and fasting insulin levels
were compared in 1 7 lean controls, 85 nondiabetic obese,
39 glucose-impaired obese, 29 NIDDM obese with fasting
blood sugar < 140 mg/dL, and 25 NIDDM obese with
fasting blood sugar > 140 mg/dL. The data, shown in
Figures 7 and 8, suggest that insulin production continues
to rise with increasing insulin resistance until, finally, the
beta cells fail to reach effective insulin production on de-
mand and, as a consequence, blood glucose levels rise out
of control. In short, the progression of the two diseases,
NIDDM and obesity, parallel each other. The diabetes,
these data suggest, appears to be due to ever-increasing
insulin resistance and the eventual failure ofthe pancreas
to meet the ever higher demand for insulin production.
In a way, type II diabetes mellitus, at its most severe and
terminal point, resembles type 1 diabetes, with inadequate
insulin production.
Control ofHypertension
The GGB favorably affected hypertension. Of the 515
patients, 301 (58.4%) were hypertensive before the oper-
ation and, ofthese, 169 (56.1%) were on antihypertensive
medication. After the GGB, 96 of the 301 (31.9%) re-
mained hypertensive, and 88 (29.2%) were maintained
on antihypertensive therapy.
Perioperative and Late Complications
The perioperative mortality rate was 1.2%, in other
words, six of 515 patients died within 30 days after their
operation or during their first hospitalization, a low rate
in view of the fact that 47 (9.1%) of these patients in the
series were, in addition to being severely obese, also in
cardiopulmonary failure before surgery. As demonstrated
in Table 5, 83% ofthe perioperative deaths were of sepsis.
There were 17 late deaths, of which 7 (41.1%) were
related to emotional problems: three were suicides, two
died of cirrhosis due to alcohol abuse, and two died of
self-imposed malnutrition. Another three, those from
motor vehicle fatalities, are suspect because depression or
other emotional factors are frequently involved in car
crashes. The investigating authorities, however, have cited
all three as accidents and we have been unable to obtain
any further details. The death of acquired immune defi-
ciency syndrome was caused by an infection transmitted
from a transfusion during a plastic surgery procedure at
another hospital; the unknown death appears to have been
a result of an arrhythmia.
Perioperative complications are listed in Table 6.
Wound problems and infections are the most common
cause of prolonged hospitalization in the severely obese,
probably related to the high incidence ofNIDDM. Table
7 lists those late complications that occur at a rate of 1%
or greater. The most common problems seen over the 11
years of follow-up include depression and other psychiatric
problems; vitamin and iron deficiencies; incisional her-
nias; cholecystitis; and technical problems associated with
the operation such as staple line failures, anastomotic di-
latations or stenoses, and bowel obstructions due to adhe-
sions.
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FIG. 3. Comparison between the postoperative fasting blood glucose levels
in patients with NIDDM and preoperative plasma glucose readings of
<120 mg/dL and >120 mg/dL. Patients with the higher preoperative
glucose values experienced greater decreases in plasma glucose than their
more normal counterparts, but leveled out at values that were still not
fully normal.
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FIG. 4. Drop in insulin levels after
the gastric bypass.
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Discussion
One of the main goals in the management of NIDDM
is euglycemia through weight control. Unfortunately, most
patients with NIDDM are overweight, and further,
NIDDM is especially common in patients who are severely
obese, in other words, who exceed their ideal body weight
by 100 pounds or more. Diets do not work in these mas-
sive individuals, and the general course of their illness is
a pattern of ever-increasing weight, worsening diabetes,
and progression of diabetic complications. Our data sug-
gest that surgical intervention with the gastric bypass offers
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FIG. 6. Changes in fasting blood glucose levels after the gastric bypass.
A great number of patients have reverted to normal values.
a new and reasonable approach to the control ofNIDDM
in the severely obese and perhaps in those who are mod-
erately obese as well.
On March 25 through 27, 1991, the National Institutes
of Health held a Consensus Conference on Gastrointes-
tinal Surgery for Severe Obesity to examine the effective-
ness of bariatric surgery. First, the panel concurred that
severe obesity is an increasingly common problem: "The
disorder is accompanied by reduced life expectancy and
significant psychosocial and economic problems are fre-
quently experienced by severely obese people." There is
a direct relationship between the amount ofexcess weight
and the incidence of arthritis, coronary artery disease, ce-
rebrovascular disease, congestive heart failure, hyperten-
sion, diabetes mellitus, cholecystitis, and cancers of the
stomach, uterus, and breast.'4"5 In addition, as they con-
tinue to get older and gain ever more weight, these indi-
viduals develop other health problems associated with se-
vere obesity, including hypertension, cardiopulmonary
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failure, Pickwickian syndrome, sleep apnea, hyperlipid-
emia, coronary artery disease, gout, certain cancers, cho-
lelithiasis, hepatic steatosis, polycystic ovary syndrome,
pseudotumor cerebri, osteoarthritis, cardiomyopathy,
hormonal abnormalities, and skin disease.
Patients, however, usually seek surgical intervention
because of limitations in function rather than for health
indications.'6 Fat people are frequently objects of public
scorn and malicious ridicule. Employers are often reluc-
tant to hire them because they are considered unattractive,
have high rates of absenteeism due to illness, fall asleep
on the job, and are thought to have a higher accident rate
in factories because oftheir clumsiness and loose clothing.
Obesity limits the availability ofeducational opportunities
and a chance to find a spouse. Finally, our patients fre-
quently mention their inabilities to meet their parental
and other social roles: their children and other family
members are ashamed to be seen with them at school, at
athletic events, and in social situations. In short, the en-
vironment ofthe severely obese is neither happy nor filled
with opportunities. Kral et al.'7 summarized their prob-
lems well when they concluded that the severely obese
are handicapped by every measure: physically, emotion-
ally, economically, and socially. Morbid obesity is indeed
a serious disease; if diabetes is present as well, it becomes
even more dangerous.
The estimated annual mortality rate in sudden death
among the severely obese is 65/100,000, in other words,
40 times higher than expected in the general population."
An American Cancer Society study"8 disclosed deaths
from all causes to be 50% higher among men and women
who were merely 30% to 40% above normal weight. Mor-
tality rate accelerates steeply when an individual becomes
50% overweight; for example, young severely obese males
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FIG. 7. Insulin resistance in normal and obese patients with and without diabetes as reflected by the oral glucose tolerance curves in 1 7 normal lean
patients, 85 normal obese patients, 39 obese patients with IGT, 29 obese patients with NIDDM with FBS < 140 mg/dL, and 25 obese patients with
NIDDM with FBS > 140 mg/dL.
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FIG. 8. Insulin resistance as reflected by the rise in fasting insulin levels
in normal lean patients, normal obese patients, impaired obese patients,
and diabetic patients with FBS < 140 mg/dL and > 140 mg/dL.
have a 12-fold increase in mortality rate.'9 Bray's20 data,
shown in Figure 9, graphically demonstrate the relation-
ship of mortality to the body mass index (kg/M2).
Second, the National Institutes of Health panel agreed
that surgery has become the therapy ofchoice. According
to the summary of the conference, more than 12 million
Americans are severely overweight, and 4 million ofthese
are "so overweight that their obesity harms their health
and well-being, making them candidates for surgical
treatment."21 The panel endorsed two surgical treatments
for severe obesity: vertical banded gastroplasty and the
Roux-en-Y gastric bypass operation. These two proce-
dures, gradually improved over the last three decades, can
now safely and effectively control weight over long periods
TABLE 5. Deaths With Greenville Gastric Bypass
After]1 Years'Follow-up
Cause N
Perioperative
Sepsis 5
Pulmonary embolus I
6/5 15 (1.2%)
Late
Suicide 3
Auto accident 3
Cirrhosis 2
Cancer
Liver I
Larynx I
Myocardial infarction I
Anemia, pernicious I
Non-GGB sepsis I
Malnutrition 1
AIDS 1
Unknown I
Positional asphyxia 1
17/515 (3.3%)
Total deaths 23/515 (4.5%)
GGB, Greenville gastric bypass.
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TABLE 6. Perioperative Complications With Greenville Gastric Bypass
After 11 Years' Follow-up (N = 515)
Complication Label N
Wound complications
Minor wound infection 50 (9.7%)
Wound seroma 35 (6.8%)
Severe wound infection 18 (3.5%)
Wound dehiscence 5 (1.0%)
Operative complications
Spleen tear or laceration 13 (2.5%)
Subphrenic abscess 12 (2.3%)
Liver tear 8 (1.6%)
General complications after operation
Temperature 45 (8.7%)
Anastomosis/stenosis 10 (1.9%)
Arrythmia 8 (1.6%)
Readmit 41 (8.0%)
Reoperate 12 (2.3%)
Patients with 2 1 perioperative complications 315 (61.2%)
and either reverse or avoid many of the health and social
problems associated with severe obesity. These operations
are, however, not the only bariatric operations that ame-
liorate or reverse diabetes. Most operations reported to
induce weight loss, including the intestinal bypasses, gas-
tric bypasses, and gastroplasties, have shown this effect.
It is our impression that the gastric bypass, with its bypass
of the hormonal axis of the foregut and greater weight
loss, does this more effectively than the gastroplasties, but
our evidence for this remains fragmentary.
Conclusion
The gastric bypass operation is an effective therapy for
the treatment of NIDDM in the severely obese. The op-
eration can be done with acceptable morbidity and mor-
tality rates, and the effects ofthe procedure are well main-
tained over 11 years of observation. The procedure, with
the modification that divides rather than staples the stom-
ach, should now be considered for obese patients who are
TABLE 7. Late Complications With Greenville Gastric Bypass
After 11 Years'Follow-up (N= 507)
Complication Label N
Vitamin deficiency 233 (46.0%)
Anemia 232 (45.8%)
Readmit 187 (39.6%)
Depression 121 (23.9%)
Incisional hernia 107 (21.1%)
Gastritis 65 (12.8%)
Cholelithiasis 60 (11.8%)
Staple line failure 49 (9.7%)
Small bowel obstruction 28 (5.5%)
Dehydration/malnutrition 28 (5.5%)
Anastomosis failure 26 (5.1%)
Revision 25 (4.9%)
Ulcer 23 (4.5%)
Dilated pouch 17 (3.4%)
Anastomosis stenosis 15 (3.0%)
* Eight patients < 30 days after surgery.
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FIG. 9. Mortality rate rises sharply
from all causes with increases in the
BMI (kg/M2). For reference, a
woman 5'5" tall, with an ideal body
weight of 134 lb. according to the
1983 Height and Weight Standards
of the Metropolitan Life Insurance
Company Tables has a BMI of 22.3.
With a BMI of 30, 35, or 40, she
would weigh 179 lb, 210 lb, or 240
lb, respectively. Patients are consid-
ered "clinically severely obese" or
"morbidly obese" if they exceed a
BMI of 35 with comorbid conditions
or a BMI of 40 without obesity-as-
sociated illnesses. Reproduced with
permission from Bray.20
I I I
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not heavy enough to be classified as severely obese, but
whose diabetes is difficult to control. Whether the eugly-
cemia and restoration of normal insulin levels prevents
the long-term development of diabetic complications re-
mains unknown.
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